Testing: Tissue Testing

When a biopsy is taken from a tumor, the tissue must be analyzed for cell abnormalities to determine if it is cancerous and malignant. Analysis also reveals the type of cancer the patient has.

The first type of test uses a process called flow cytometry. Flow cytometry is done in a high-tech machine. The process sorts through the cells from the biopsy and examines them for certain cell markers that are found in the membranes of cells. These markers, called clusters of differentiation (CD), identify certain types of cancer cells.

The second test examines the DNA of biopsied cells. Laboratory technicians examine DNA for genetic abnormalities. These abnormalities cause the mutations in cancerous cells, which causes them to grow faster than normal, healthy cells, thus creating a tumor. Identification of these abnormalities helps classify cancer.

Once the biopsied tissue is examined using both of these techniques, the doctor can identify the type of cancer a patient has and then perform the necessary tests to stage the disease.

These tests are also useful in determining the type of treatment to give a patient. Some cell markers bind with antibodies – "tags" that mark the cell for removal by the immune system – so immunotherapy can be used. For more information on this type of treatment, please see the article titled Monoclonal Antibody Therapy.

Dive Deeper

For more information on Hodgkin's disease, please see the following pages

For more information on Non-Hodgkin lymphoma, please see the following pages:

More Articles

More Articles

In T cell lymphoma, T lymphocytes, which are an essential part of the body's immune response, become malignant. T cell lymphomas account for about...

Lymphomatoid Papulosis (LyP) is a rare skin disorder that involves cancerous looking skin lesions. It is more than a skin condition; it is the...

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is a relatively rare B-cell subtype of non-Hodgkin'...

T-Cell Lymphoblastic Lymphoma (T-LBL) is a very rare subtype of non-Hodgkin's lymphoma. It tends to develop in...

In general, a diagnosis of T-cell lymphoma denotes a poorer prognosis than a diagnosis of B-cell lymphoma. One of...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...